Portfolio
Corner Office
Culture
Premium
Opinion
Research
Video
Innovation
Subscribe
Sign In
Register

Subscribe Sign In Register

Portfolio
Corner Office
Culture
Premium
Opinion
Research
Video
Innovation
Subscribe
Sign In
Register

Search Query

Sam Isaly

Premium

OrbiMed gains on Amarin’s hearty rally

April 30, 2011

Premium

Orbimed drug portfolio balances prognosis with prevention

September 22, 2009

Corporate
- Masthead
- About Us
- Management
- Customer Service
- FAQs
- Cookies
- Reprints
- II Press Room
Publications
- II Research
- RIA Intel
Research
- Research FAQs
- Subscribe to Research
Advertising
Events
Subscription
- Subscribe to Premium
- Subscribe to Research
- Register
  - Register for Free Account

© 2024 Institutional Investor LLC. All material subject to strictly enforced copyright laws.Institutional Investor LLC is part of the Delinian group. Please read our Terms and Conditions, Modern Slavery Act Transparency Statement, and Privacy Policy before using the site.

twitter
instagram
facebook
linkedin